Log in

OTCMKTS:ENZNEnzon Pharmaceuticals Stock Price, Forecast & News

+0.03 (+15.25 %)
(As of 08/7/2020 04:00 PM ET)
Today's Range
Now: $0.23
50-Day Range
MA: $0.17
52-Week Range
Now: $0.23
Volume183,817 shs
Average Volume70,832 shs
Market CapitalizationN/A
P/E Ratio1.43
Dividend YieldN/A
Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in licensing drug products. Its marketed drug products include PegIntron for use in the treatment of chronic hepatitis C; and Sylatron for use in the treatment of melanoma disease. The company was founded in 1981 and is headquartered in Cranford, New Jersey.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.81 out of 5 stars

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Current SymbolOTCMKTS:ENZN
Previous SymbolNASDAQ:ENZN



Sales & Book Value

Annual Sales$210,000.00
Book Value$0.14 per share


Net Income$-980,000.00
Net Margins-1,745.90%


Next Earnings Date11/4/2020 (Estimated)
OptionableNot Optionable
+0.03 (+15.25 %)
(As of 08/7/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ENZN News and Ratings via Email

Sign-up to receive the latest news and ratings for ENZN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Enzon Pharmaceuticals (OTCMKTS:ENZN) Frequently Asked Questions

How has Enzon Pharmaceuticals' stock been impacted by COVID-19 (Coronavirus)?

Enzon Pharmaceuticals' stock was trading at $0.1693 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ENZN stock has increased by 36.1% and is now trading at $0.2305.
View which stocks have been most impacted by Coronavirus

When is Enzon Pharmaceuticals' next earnings date?

Enzon Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Enzon Pharmaceuticals

How were Enzon Pharmaceuticals' earnings last quarter?

Enzon Pharmaceuticals Inc (OTCMKTS:ENZN) posted its quarterly earnings results on Thursday, April, 30th. The biotechnology company reported ($0.01) EPS for the quarter. Enzon Pharmaceuticals had a negative return on equity of 17.93% and a negative net margin of 1,745.90%.
View Enzon Pharmaceuticals' earnings history

Has Enzon Pharmaceuticals been receiving favorable news coverage?

Press coverage about ENZN stock has trended very positive on Saturday, InfoTrie Sentiment reports. The research group identifies negative and positive press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Enzon Pharmaceuticals earned a news sentiment score of 4.0 on InfoTrie's scale. They also assigned news articles about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days.
View the latest news about Enzon Pharmaceuticals

Who are some of Enzon Pharmaceuticals' key competitors?

What other stocks do shareholders of Enzon Pharmaceuticals own?

Who are Enzon Pharmaceuticals' key executives?

Enzon Pharmaceuticals' management team includes the following people:
  • Mr. Andrew Rackear, CEO & Sec. (Age 65)
  • Mr. Richard L. Feinstein, VP of Fin. & CFO (Age 76)

What is Enzon Pharmaceuticals' stock symbol?

Enzon Pharmaceuticals trades on the OTCMKTS under the ticker symbol "ENZN."

How do I buy shares of Enzon Pharmaceuticals?

Shares of ENZN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Enzon Pharmaceuticals' stock price today?

One share of ENZN stock can currently be purchased for approximately $0.23.

What is Enzon Pharmaceuticals' official website?

The official website for Enzon Pharmaceuticals is www.enzon.com.

How can I contact Enzon Pharmaceuticals?

Enzon Pharmaceuticals' mailing address is 20 Commerce Drive Suite 135, Cranford NJ, 07016. The biotechnology company can be reached via phone at 732-980-4500 or via email at [email protected]

This page was last updated on 8/8/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.